Worldwide Clinical Trials
JUNE 15, 2022
We’ve also seen a decrease in available research nurses, as they have had to be reassigned to COVID patients. It really is—there has been a 10x increase in cell and gene therapies in the clinical development pipeline since 2012. Fewer staff creates many problems, including less bandwidth to meet for reviews and approvals.
Drug Discovery World
MAY 28, 2023
Versameb is a next generation RNA company taking action in the treatment of this unmet need, with a lead candidate programme in SUI. The company has developed a proprietary technology platform, VERSagile, which optimises the application of functional RNA in different disease contexts.
XTalks
SEPTEMBER 14, 2020
The company’s candidate vaccine, mRNA-1273, is a synthetic messenger RNA that encodes the stabilized SARS-CoV-2 spike protein. That said, the percentage of all COVID-19 deaths that occurred in nursing homes, standing at 81 percent, is the highest in the world followed by Spain at 66 percent.
Expert insights. Personalized for you.
130 
Let's personalize your content